Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pranav Gupta

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
NPJ Science of Food|January 20, 2026
A unified knowledge graph linking foodomics to chemical-disease networks and flavor profilesFangzhou Li, Jason Youn, Kaichi Xie, et al.
Journal of Pharmacy & Bioallied Sciences|August 27, 2021
COVID and Animal Trials: A Systematic ReviewMuhamood Moothedath, Muhaseena Muhamood, Yadnit S Bhosale, et al.
Oncotarget|October 10, 2014
CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisPranav Gupta, Praveen K Sharma, Hina Mir, et al.
Journal of Proteomics & Bioinformatics|September 7, 2013
Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate CancerChristelle P El-Haibi, Rajesh Singh, Pranav Gupta, et al.
Cancer Letters|November 5, 2018
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivoAlbert A De Vera, Pranav Gupta, Zining Lei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2025
Targeting protein misfolding in Alzheimer's disease: The emerging role of molecular chaperonesAnushka Sharma, Shriyansh Srivastava, Pranav Gupta, et al.
Cancer Letters|October 11, 2016
PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemiaPranav Gupta, Rishil J Kathawala, Liuya Wei, et al.
Chemmedchem|April 10, 2024
Chemical Derivatization Leads to the Discovery Of Novel Analogs of Azotochelin, a Natural Siderophore, as Promising Anticancer AgentsNishant M Karadkhelkar, Pranav Gupta, Leonard Barasa, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 6, 2015
The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation thresholdLaura Michelle Mason, María Dolores Campiñez, Samuel R Pygall, et al.
Experimental Cell Research|April 3, 2020
Plasminogen activator inhibitor (PAI) trap3, an exocellular peptide inhibitor of PAI-1, attenuates the rearrangement of F-actin and migration of cancer cellsJihao Liu, Zhuo Chen, Mingdong Huang, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
NPJ Science of Food|January 20, 2026
A unified knowledge graph linking foodomics to chemical-disease networks and flavor profilesFangzhou Li, Jason Youn, Kaichi Xie, et al.
Journal of Pharmacy & Bioallied Sciences|August 27, 2021
COVID and Animal Trials: A Systematic ReviewMuhamood Moothedath, Muhaseena Muhamood, Yadnit S Bhosale, et al.
Oncotarget|October 10, 2014
CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisPranav Gupta, Praveen K Sharma, Hina Mir, et al.
Journal of Proteomics & Bioinformatics|September 7, 2013
Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate CancerChristelle P El-Haibi, Rajesh Singh, Pranav Gupta, et al.
Cancer Letters|November 5, 2018
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivoAlbert A De Vera, Pranav Gupta, Zining Lei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2025
Targeting protein misfolding in Alzheimer's disease: The emerging role of molecular chaperonesAnushka Sharma, Shriyansh Srivastava, Pranav Gupta, et al.
Cancer Letters|October 11, 2016
PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemiaPranav Gupta, Rishil J Kathawala, Liuya Wei, et al.
Chemmedchem|April 10, 2024
Chemical Derivatization Leads to the Discovery Of Novel Analogs of Azotochelin, a Natural Siderophore, as Promising Anticancer AgentsNishant M Karadkhelkar, Pranav Gupta, Leonard Barasa, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 6, 2015
The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation thresholdLaura Michelle Mason, María Dolores Campiñez, Samuel R Pygall, et al.
Experimental Cell Research|April 3, 2020
Plasminogen activator inhibitor (PAI) trap3, an exocellular peptide inhibitor of PAI-1, attenuates the rearrangement of F-actin and migration of cancer cellsJihao Liu, Zhuo Chen, Mingdong Huang, et al.
Pageof 13